| | Gender/age | Shock state | Vasopressor | Underlying disease | Involved region | Amputation level | Type of flap | Flap size (cm) | Pedicle length (cm) | Recipient vessels | Donor site | Early complications | Late complications | Ambulation
(FAC) | Follow-up
(month) |
| | M/44 | Septic shock | Epinephrine | HTN, DM | Feet, both | Transmetatarsal amputation, Rt. | TDAP | 7 × 11 | 7 | ATA, AV | Primary closure | None | | 6 | 18 |
| | M/46 | Respiratory arrest | Epinephrine | HTN, DM | Feet, both hands, both | Transmetatarsal amputation, Rt. | TDAP | 8 × 10 | 10 | PTA, AV | Primary closure | None | | 6 | 12 | | Transmetatarsal amputation, Lt. | TDAP, STSG | 9 × 11 | 10 | PTA, AV | Primary closure | None |
| | M/60 | Hypovolemic shock | Dopamine | Aortic dissection
(Aorto-bi-iliac bypass graft state) | Foot, Rt. | Lisfranc amputation, Rt. | TDAP | 8 × 12 | 8 | ATA, AV | Primary closure | None | Chronic ulcer | 5 | 54 |
| | F/60 | Septic shock | Norphin | HTN, DM, ESRD, CHF, PTE | Feet, both | Lisfranc amputation, Rt. | TDAP & LDm | 9 × 12 | 7 | ATA, AV | Primary closure | Partial necrosis | | 4 | 12 | | (Chimeric) | (4 × 4) | | Transmetatarsal amputation, Lt. | TDAP | 20 × 12 | 7 | PTA, GSV | STSG coverage | None |
| | F/57 | Septic shock | Dopamine | HTN, DM | Feet, both hands, both | Transmetatarsal amputation, Rt. | TDAP | 20 × 15 | 7 | PTA, AV | STSG coverage | Partial necrosis, STSG | | 4 | 6 | | Transmetatarsal amputation, Lt. | TDAP | 25 × 15 | 11 | ATA, AV | STSG coverage | None |
| | F/69 | Septic shock | Norphin | HTN, DM | Feet, both | Transmetatarsal amputation, Rt. | TDAP | 15 × 10 | 7 | ATA, AV | Primary closure | None | Chronic | 5 | 6 | | Transmetatarsal amputation, Lt. | TDAP, STSG | 25 × 15 | 11 | PTA, AV | STSG coverage | Partial necrosis | Osteomyelitis |
|
|
